Paul Glyer
Fondateur chez IOI Partners LLC
Profil
Paul Glyer is the founder of IOI Partners LLC, which was founded in 2014.
He is currently a Director at 1 For 2 Education Foundation, Axalbion Therapeutics Ltd., and a Board Member at Vennfi, Inc. He is also an Executive Advisor at Water Street Healthcare Partners LLC and the President of Kolstrand, LLC.
Mr. Glyer's former job was as the SVP of Strategy, Business Development & Comms at Beckman Coulter, Inc. from 2005 to 2011.
He received his undergraduate degree from The California State University in 1983 and his MBA from Peter F Drucker & Masatoshi Ito Graduate School of Management in 1986.
Postes actifs de Paul Glyer
| Sociétés | Poste | Début |
|---|---|---|
Vennfi, Inc.
 Vennfi, Inc. Packaged SoftwareTechnology Services Vennfi, Inc. is a charity organization that simplifies the complex financial product of philanthropy, making it more accessible to donors of all sizes. The organization is headquartered in GA and partners with a venture-backed software company, Vennfi Charityvest, a sponsor of modern donor-advised funds, has facilitated nearly $100 million in total giving across thousands of donors. The American company offers a tax-smart giving account to donate cash, stock, and crypto to favorite charities and manage charitable giving with purpose. The company was founded by Koon David Jon, Paul Ashby Foltz, James Stephen Kump, and James Stephen Kump has been the CEO since incorporation. | Directeur/Membre du Conseil | 01/08/2017 |
IOI Partners LLC
 IOI Partners LLC Miscellaneous Commercial ServicesCommercial Services IOI Partners LLC provides business advisory services. The company is based in Zionsville, IN. The company was founded by Scott Atkin, Paul Glyer. | Fondateur | 01/01/2014 |
Water Street Healthcare Partners LLC
 Water Street Healthcare Partners LLC Investment ManagersFinance Water Street Healthcare Partners LLC (Water Street Healthcare Partners) is a private equity firm founded in 2005. The firm is headquartered in Chicago, Illinois. | Consultant / Advisor | 01/12/2012 |
| 1 For 2 Education Foundation | Directeur/Membre du Conseil | 01/01/2014 |
| Kolstrand, LLC | President | 01/04/2008 |
Axalbion Therapeutics Ltd.
 Axalbion Therapeutics Ltd. BiotechnologyHealth Technology Axalbion Therapeutics Ltd. has developed a drug candidate for several therapeutic applications. The private company is based in Wythenshawe, UK. The British company has evaluated new patented TRPM8 agonists, which are molecular transducers expressed in sensory neurons. The TRPM8 ion channel is expressed by approximately 10-15% of somatosensory neurons. Axalbion Therapeutics focuses on treating dry eye syndrome (DES), which is a disorder of the tear film due to tear deficiency. The company was founded in 2021, and the CEO is Michael M. Kitt. | Directeur/Membre du Conseil | - |
Anciens postes connus de Paul Glyer
| Sociétés | Poste | Fin |
|---|---|---|
Beckman Coulter, Inc.
 Beckman Coulter, Inc. Medical SpecialtiesHealth Technology Beckman Coulter, Inc. manufactures and distributes biomedical testing instrument systems and general biomedical research products. It develops and markets products that simplify, automate and innovate complex biomedical testing. The firm’s systems operate in both diagnostics and life sciences laboratories on seven continents. Its products improve the productivity of medical professionals and scientists, supplying critical information for improving patient health and delivering trusted solutions for research and discovery. The company was founded in 1935 by Arnold O. Beckman and is headquartered in Brea, CA. | Corporate Officer/Principal | 01/01/2011 |
Formation de Paul Glyer
| The California State University | Undergraduate Degree |
| Peter F Drucker & Masatoshi Ito Graduate School of Management | Masters Business Admin |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 7 |
|---|---|
Beckman Coulter, Inc.
Beckman Coulter, Inc. Medical SpecialtiesHealth Technology Beckman Coulter, Inc. manufactures and distributes biomedical testing instrument systems and general biomedical research products. It develops and markets products that simplify, automate and innovate complex biomedical testing. The firm’s systems operate in both diagnostics and life sciences laboratories on seven continents. Its products improve the productivity of medical professionals and scientists, supplying critical information for improving patient health and delivering trusted solutions for research and discovery. The company was founded in 1935 by Arnold O. Beckman and is headquartered in Brea, CA. | Health Technology |
Water Street Healthcare Partners LLC
Water Street Healthcare Partners LLC Investment ManagersFinance Water Street Healthcare Partners LLC (Water Street Healthcare Partners) is a private equity firm founded in 2005. The firm is headquartered in Chicago, Illinois. | Finance |
Vennfi, Inc.
Vennfi, Inc. Packaged SoftwareTechnology Services Vennfi, Inc. is a charity organization that simplifies the complex financial product of philanthropy, making it more accessible to donors of all sizes. The organization is headquartered in GA and partners with a venture-backed software company, Vennfi Charityvest, a sponsor of modern donor-advised funds, has facilitated nearly $100 million in total giving across thousands of donors. The American company offers a tax-smart giving account to donate cash, stock, and crypto to favorite charities and manage charitable giving with purpose. The company was founded by Koon David Jon, Paul Ashby Foltz, James Stephen Kump, and James Stephen Kump has been the CEO since incorporation. | Technology Services |
IOI Partners LLC
IOI Partners LLC Miscellaneous Commercial ServicesCommercial Services IOI Partners LLC provides business advisory services. The company is based in Zionsville, IN. The company was founded by Scott Atkin, Paul Glyer. | Commercial Services |
| 1 For 2 Education Foundation | |
| Kolstrand, LLC | |
Axalbion Therapeutics Ltd.
Axalbion Therapeutics Ltd. BiotechnologyHealth Technology Axalbion Therapeutics Ltd. has developed a drug candidate for several therapeutic applications. The private company is based in Wythenshawe, UK. The British company has evaluated new patented TRPM8 agonists, which are molecular transducers expressed in sensory neurons. The TRPM8 ion channel is expressed by approximately 10-15% of somatosensory neurons. Axalbion Therapeutics focuses on treating dry eye syndrome (DES), which is a disorder of the tear film due to tear deficiency. The company was founded in 2021, and the CEO is Michael M. Kitt. | Health Technology |
